Eric Henry, AI in MedTech expert, and Etienne Nichols discuss the evolving landscape of AI in MedTech, focusing on regulatory compliance and the future of AI in medical devices. They explore the role of FDA and FTC, the implications of generative AI, and the potential revolution in quality management systems. The FTC's growing role and algorithmic disgorgement are highlighted, along with the importance of pre-market and post-market oversight.